Genre image
Photo: Depositphotos

KKR wants to buy Biotage in 11,6 Billion SEK Deal

Advertisement

The private equity firm KKR wants to buy out Biotage from the stock exchange. KKR is offering 145 kronor in cash per share, which values the biotech company at 11.6 billion kronor, according to a press release.

Biotage's board of directors recommends that shareholders accept the offer.

In this story
AuthorTT News AgencyEnglish edition by Sweden Herald, adapted for our readers
Was this useful?

What do you think?

Keep readingmore from Business

All